King of Prussia biopharm's drug application rejected by FDA for second time

The drug is under development as a treatment for complex urinary tract infections.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 20, 2020 Category: Pharmaceuticals Authors: John George Source Type: news